Mechanisms, treatment and prevention of cellular injury and death from delayed events after aneurysmal subarachnoid hemorrhage

Bibliography

• Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology 2010;74:1494-501
   PubMed Web of Science ®Google Scholar
• Hijdra A, van GJ, Stefanko S, et al. Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: clinicoanatomic correlations. Neurology 1986;36:329-33
   PubMed Web of Science ®Google Scholar
• Vergouwen MD, Vermeulen M, van GJ, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 2010;41:2391-5
   PubMed Web of Science ®Google Scholar
• Rabinstein AA, Friedman JA, Weigand SD, et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004;35:1862-6
   PubMed Web of Science ®Google Scholar
• Griffiths PD, Wilkinson ID, Mitchell P, et al. Multimodality MR imaging depiction of hemodynamic changes and cerebral ischemia in subarachnoid hemorrhage. AJNR Am J Neuroradiol 2001;22:1690-7
   PubMed Web of Science ®Google Scholar
• Loch MR. Management of cerebral vasospasm. Neurosurg Rev 2006;29:179-93
   PubMed Web of Science ®Google Scholar
• Sehba FA, Friedrich V. Early micro vascular changes after subarachnoid hemorrhage. Acta Neurochir Suppl 2011;110:49-55
   PubMedGoogle Scholar
• Vergouwen MD, Vermeulen M, Coert BA, et al. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 2008;28:1761-70
   PubMed Web of Science ®Google Scholar
• Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 2011;17:439-47
   PubMed Web of Science ®Google Scholar
• Ayer RE, Zhang JH. Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir Suppl 2008;104:33-41
   PubMedGoogle Scholar
• Provencio JJ, Vora N. Subarachnoid hemorrhage and inflammation: bench to bedside and back. Semin Neurol 2005;25:435-44
   PubMed Web of Science ®Google Scholar
• Velat GJ, Kimball MM, Mocco JD, Hoh BL. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. World Neurosurg 2011;76:446-54
   PubMed Web of Science ®Google Scholar
• Jones TH, Morawetz RB, Crowell RM, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981;54:773-82
   PubMed Web of Science ®Google Scholar
• Brittain MK, Brustovetsky T, Sheets PL, et al. Delayed calcium dysregulation in neurons requires both the NMDA receptor and the reverse Na+/Ca2+ exchanger. Neurobiol Dis 2012;46:109-17
   PubMed Web of Science ®Google Scholar
• Napper GA, Pianta MJ, Kalloniatis M. Reduced glutamate uptake by retinal glial cells under ischemic/hypoxic conditions. Vis Neurosci 1999;16:149-58
   PubMed Web of Science ®Google Scholar
• Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci 2001;69:369-81
   PubMed Web of Science ®Google Scholar
• Cohen JJ, Duke RC. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 1984;132:38-42
   PubMed Web of Science ®Google Scholar
• Sharma AK, Rohrer B. Calcium-induced calpain mediates apoptosis via caspase-3 in a mouse photoreceptor cell line. J Biol Chem 2004;279:35564-72
   PubMed Web of Science ®Google Scholar
• Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991;22:971-82
   PubMed Web of Science ®Google Scholar
• Zhang ZD, Yamini B, Komuro T, et al. Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot. Stroke 2001;32:1868-74
   PubMed Web of Science ®Google Scholar
• Thampatty BP, Sherwood PR, Gallek MJ, et al. Role of endothelin-1 in human aneurysmal subarachnoid hemorrhage: associations with vasospasm and delayed cerebral ischemia. Neurocrit Care 2011;15:19-27
   PubMed Web of Science ®Google Scholar
• Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008;39:3015-21
   PubMed Web of Science ®Google Scholar
• Dorsch N. A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture. Acta Neurochir Suppl 2011;110:5-6
   PubMedGoogle Scholar
• Dorsch NW, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part I: incidence and effects. J Clin Neurosci 1994;1:19-26
   PubMedGoogle Scholar
• Feigin VL, Rinkel GJ, Algra A, et al. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 1998;50:876-83
   PubMed Web of Science ®Google Scholar
• Stein SC, Levine JM, Nagpal S, LeRoux PD. Vasospasm as the sole cause of cerebral ischemia: how strong is the evidence? Neurosurg Focus 2006;21:E2
   PubMedGoogle Scholar
• Ohkuma H, Manabe H, Tanaka M, Suzuki S. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2000;31:1621-7
   PubMed Web of Science ®Google Scholar
• Crowley RW, Medel R, Dumont AS, et al. Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 2011;42:919-23
   PubMed Web of Science ®Google Scholar
• Dhar R, Scalfani MT, Blackburn S, et al. Relationship between angiographic vasospasm and regional hypoperfusion in aneurysmal subarachnoid hemorrhage. Stroke 2012;43:1788-94
   PubMed Web of Science ®Google Scholar
• Ohkuma H, Itoh K, Shibata S, Suzuki S. Morphological changes of intraparenchymal arterioles after experimental subarachnoid hemorrhage in dogs. Neurosurgery 1997;41:230-5
   PubMed Web of Science ®Google Scholar
• Perkins E, Kimura H, Parent AD, Zhang JH. Evaluation of the microvasculature and cerebral ischemia after experimental subarachnoid hemorrhage in dogs. J Neurosurg 2002;97:896-904
   PubMed Web of Science ®Google Scholar
• Pennings FA, Bouma GJ, Ince C. Direct observation of the human cerebral microcirculation during aneurysm surgery reveals increased arteriolar contractility. Stroke 2004;35:1284-8
   PubMed Web of Science ®Google Scholar
• Uhl E, Lehmberg J, Steiger HJ, Messmer K. Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging. Neurosurgery 2003;52:1307-15
   PubMed Web of Science ®Google Scholar
• Pennings FA, Albrecht KW, Muizelaar JP, et al. Abnormal responses of the human cerebral microcirculation to papaverin during aneurysm surgery. Stroke 2009;40:317-20
   PubMed Web of Science ®Google Scholar
• Friedrich B, Muller F, Feiler S, et al. Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in-vivo microscopy study. J Cereb Blood Flow Metab 2012;32:447-55
   PubMed Web of Science ®Google Scholar
• Pluta RM, Oldfield EH. Analysis of nitric oxide (NO) in cerebral vasospasm after aneursymal bleeding. Rev Recent Clin Trials 2007;2:59-67
   PubMedGoogle Scholar
• Suzuki S, Kimura M, Souma M, et al. Cerebral microthrombosis in symptomatic cerebral vasospasm–a quantitative histological study in autopsy cases. Neurol Med Chir (Tokyo) 1990;30:309-16
   PubMedGoogle Scholar
• Romano JG, Forteza AM, Concha M, et al. Detection of microemboli by transcranial Doppler ultrasonography in aneurysmal subarachnoid hemorrhage. Neurosurgery 2002;50:1026-30
   PubMed Web of Science ®Google Scholar
• Hirashima Y, Nakamura S, Endo S, et al. Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochem Res 1997;22:1249-55
   PubMed Web of Science ®Google Scholar
• Nissen JJ, Mantle D, Gregson B, Mendelow AD. Serum concentration of adhesion molecules in patients with delayed ischaemic neurological deficit after aneurysmal subarachnoid haemorrhage: the immunoglobulin and selectin superfamilies. J Neurol Neurosurg Psychiatry 2001;71:329-33
   PubMed Web of Science ®Google Scholar
• Pisapia JM, Xu X, Kelly J, et al. Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan. Exp Neurol 2012;233:357-63
   PubMed Web of Science ®Google Scholar
• Paul BZ, Jin J, Kunapuli SP. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. J Biol Chem 1999;274:29108-14
   PubMed Web of Science ®Google Scholar
• Salmon JA, Higgs GA. Prostaglandins and leukotrienes as inflammatory mediators. Br Med Bull 1987;43:285-96
   PubMed Web of Science ®Google Scholar
• Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007;CD006184
   PubMed Web of Science ®Google Scholar
• Canals S, Makarova I, Lopez-Aguado L, et al. Longitudinal depolarization gradients along the somatodendritic axis of CA1 pyramidal cells: a novel feature of spreading depression. J Neurophysiol 2005;94:943-51
   PubMed Web of Science ®Google Scholar
• Sugaya E, Takato M, Noda Y. Neuronal and glial activity during spreading depression in cerebral cortex of cat. J Neurophysiol 1975;38:822-41
   PubMed Web of Science ®Google Scholar
• Dreier JP, Ebert N, Priller J, et al. Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg 2000;93:658-66
   PubMed Web of Science ®Google Scholar
• Dreier JP, Korner K, Ebert N, et al. Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab 1998;18:978-90
   PubMed Web of Science ®Google Scholar
• Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994;117(Pt 1):199-210
   PubMed Web of Science ®Google Scholar
• Windmuller O, Lindauer U, Foddis M, et al. Ion changes in spreading ischaemia induce rat middle cerebral artery constriction in the absence of NO. Brain 2005;128:2042-51
   PubMed Web of Science ®Google Scholar
• Dreier JP, Major S, Manning A, et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 2009;132:1866-81
   PubMed Web of Science ®Google Scholar
• Woitzik J, Dreier JP, Hecht N, et al. Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2012;32:203-12
   PubMed Web of Science ®Google Scholar
• Blake DR, Allen RE, Lunec J. Free radicals in biological systems–a review orientated to inflammatory processes. Br Med Bull 1987;43:371-85
   PubMed Web of Science ®Google Scholar
• Rizzo AM, Berselli P, Zava S, et al. Endogenous antioxidants and radical scavengers. Adv Exp Med Biol 2010;698:52-67
   PubMed Web of Science ®Google Scholar
• Dizdaroglu M, Jaruga P, Birincioglu M, Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med 2002;32:1102-15
   PubMed Web of Science ®Google Scholar
• Porter NA, Caldwell SE, Mills KA. Mechanisms of free radical oxidation of unsaturated lipids. Lipids 1995;30:277-90
   PubMed Web of Science ®Google Scholar
• Watanabe H, Kobayashi A, Yamamoto T, et al. Alterations of human erythrocyte membrane fluidity by oxygen-derived free radicals and calcium. Free Radic Biol Med 1990;8:507-14
   PubMed Web of Science ®Google Scholar
• Asano T. Oxyhemoglobin as the principal cause of cerebral vasospasm: a holistic view of its actions. Crit Rev Neurosurg 1999;9:303-18
   PubMedGoogle Scholar
• Lee JY, Keep RF, He Y, et al. Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury. J Cereb Blood Flow Metab 2010;30:1793-803
   PubMed Web of Science ®Google Scholar
• Horky LL, Pluta RM, Boock RJ, Oldfield EH. Role of ferrous iron chelator 2,2'-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg 1998;88:298-303
   PubMed Web of Science ®Google Scholar
• Vollmer DG, Hongo K, Ogawa H, et al. A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery 1991;28:27-32
   PubMed Web of Science ®Google Scholar
• Pyne-Geithman GJ, Nair SG, Stamper DN, Clark JF. Role of bilirubin oxidation products in the pathophysiology of DIND following SAH. Acta Neurochir Suppl 2013;115:267-73
   PubMedGoogle Scholar
• Sayama T, Suzuki S, Fukui M. Expression of inducible nitric oxide synthase in rats following subarachnoid hemorrhage. Neurol Res 1998;20:79-84
   PubMed Web of Science ®Google Scholar
• Pluta RM. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Acta Neurochir Suppl 2008;104:139-47
   PubMedGoogle Scholar
• Drouin A, Thorin-Trescases N, Hamel E, et al. Endothelial nitric oxide synthase activation leads to dilatory H2O2 production in mouse cerebral arteries. Cardiovasc Res 2007;73:73-81
   PubMed Web of Science ®Google Scholar
• Al-Tamimi YZ, Orsi NM, Quinn AC, et al. A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology. World Neurosurg 2010;73:654-67
   PubMed Web of Science ®Google Scholar
• Fassbender K, Hodapp B, Rossol S, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 2001;70:534-7
   PubMed Web of Science ®Google Scholar
• Kwon KY, Jeon BC. Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J Korean Med Sci 2001;16:774-80
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation 2004;109:2698-704
   PubMed Web of Science ®Google Scholar
• Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992;6:2591-9
   PubMed Web of Science ®Google Scholar
• Jedrzejowska-Szypulka H, Larysz-Brysz M, Kukla M, et al. Neutralization of interleukin-1beta reduces vasospasm and alters cerebral blood vessel density following experimental subarachnoid hemorrhage in rats. Curr Neurovasc Res 2009;6:95-103
   PubMed Web of Science ®Google Scholar
• Vecchione C, Frati A, Di PA, et al. Tumor necrosis factor-alpha mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage. Hypertension 2009;54:150-6
   PubMed Web of Science ®Google Scholar
• Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 2002;296:1634-5
   PubMed Web of Science ®Google Scholar
• Gomis P, Graftieaux JP, Sercombe R, et al. Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage. J Neurosurg 2010;112:681-8
   PubMed Web of Science ®Google Scholar
• Ohkuma H, Suzuki S, Ogane K, et al. Preventive effect of intracisternal methylprednisolone on symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. No Shinkei Geka 1996;24:135-42
   PubMedGoogle Scholar
• Scriabine A, van den Kerckhoff W. Pharmacology of nimodipine. A review. Ann NY Acad Sci 1988;522:698-706
   PubMed Web of Science ®Google Scholar
• Tomassoni D, Lanari A, Silvestrelli G, et al. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Clin Exp Hypertens 2008;30:744-66
   PubMed Web of Science ®Google Scholar
• McCalden TA, Nath RG, Thiele K. The effects of a calcium antagonist (nimodipine) on basal cerebral blood flow and reactivity to various agonists. Stroke 1984;15:527-30
   PubMed Web of Science ®Google Scholar
• Liu GJ, Luo J, Zhang LP, et al. Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage. CNS Neurol Disord Drug Targets 2011;10:834-44
   PubMed Web of Science ®Google Scholar
• Kronvall E, Undren P, Romner B, et al. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration. J Neurosurg 2009;110:58-63
   PubMed Web of Science ®Google Scholar
• Soppi V, Karamanakos PN, Koivisto T, et al. A randomized outcome study of enteral versus intravenous nimodipine in 171 patients after acute aneurysmal subarachnoid hemorrhage. World Neurosurg 2012;78:101-9
   PubMed Web of Science ®Google Scholar
• In brief: nimodipine oral solution (Nymalize). Med Lett Drugs Ther 2013;55:68
   PubMedGoogle Scholar
• Aschenbrenner D. Oral nimodipine given intravenously can be fatal. AJN 2010;110:27
   Web of Science ®Google Scholar
• Cook DJ, Kan S, Ai J, et al. Cisternal sustained release dihydropyridines for subarachnoid hemorrhage. Curr Neurovasc Res 2012;9:139-48
   PubMed Web of Science ®Google Scholar
• Roos YB, Levi M, Carroll TA, et al. Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage. Stroke 2001;32:1860-2
   PubMed Web of Science ®Google Scholar
• Zhu D, Li R, Liu G, Hua W. Nimodipine inhibits calcium-independent nitric oxide synthase activity in transient focal cerebral ischemia rats and cultured mouse astroglial cells. Life Sci 1999;65:L221-31
   Web of Science ®Google Scholar
• Hell JW, Westenbroek RE, Warner C, et al. Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits. J Cell Biol 1993;123:949-62
   PubMed Web of Science ®Google Scholar
• Yagami T, Ueda K, Sakaeda T, et al. Protective effects of a selective L-type voltage-sensitive calcium channel blocker, S-312-d, on neuronal cell death. Biochem Pharmacol 2004;67:1153-65
   PubMed Web of Science ®Google Scholar
• Lecht S, Rotfeld E, Arien-Zakay H, et al. Neuroprotective effects of nimodipine and nifedipine in the NGF-differentiated PC12 cells exposed to oxygen-glucose deprivation or trophic withdrawal. Int J Dev Neurosci 2012;30:465-9
   PubMed Web of Science ®Google Scholar
• Chen M, Liu A, Ouyang Y, et al. Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders? Expert Opin Investig Drugs 2013;22:537-50
   PubMed Web of Science ®Google Scholar
• Seto M, Takuwa Y, Sasaki Y. The molecular mechanism of vasospasm and the attenuation by fasudil. Nihon Yakurigaku Zasshi 1999;114(Suppl 1):66P-70P
   PubMedGoogle Scholar
• Liu GJ, Wang ZJ, Wang YF, et al. Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Eur J Clin Pharmacol 2012;68:131-9
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhou D, Guo J, et al. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurol Med Chir (Tokyo) 2011;51:679-83
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Shibuya M, Satoh S, et al. Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study. Neurol Med Chir (Tokyo) 2008;48:241-7
   PubMed Web of Science ®Google Scholar
• Kitaoka Y, Kitaoka Y, Kumai T, et al. Involvement of RhoA and possible neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina. Brain Res 2004;1018:111-18
   PubMed Web of Science ®Google Scholar
• Hiraga A, Kuwabara S, Doya H, et al. Rho-kinase inhibition enhances axonal regeneration after peripheral nerve injury. J Peripher Nerv Syst 2006;11:217-24
   PubMed Web of Science ®Google Scholar
• Yamashita K, Kotani Y, Nakajima Y, et al. Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons. Brain Res 2007;1154:215-24
   PubMed Web of Science ®Google Scholar
• Nakazawa M, Iizuka K, Ujiie A, et al. Research and development of ozagrel, a highly selective inhibitor of TXA2 synthase. Yakugaku Zasshi 1994;114:911-33
   PubMed Web of Science ®Google Scholar
• Suzuki S, Sano K, Handa H, et al. Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study. Neurol Res 1989;11:79-88
   PubMedGoogle Scholar
• Yano K, Kuroda T, Tanabe Y, Yamada H. Preventive therapy against delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: trials of thromboxane A2 synthetase inhibitor and hyperdynamic therapy. Acta Neurochir (Wien) 1993;125:15-19
   PubMed Web of Science ®Google Scholar
• Yonekawa Y, Handa H, Okamoto S, et al. Prevention of vasospasm following subarachnoid hemorrhage using a thromboxane A2 synthetase inhibitor (OKY-046)–clinical study among multiple institutions. Nihon Geka Hokan 1986;55:473-84
   PubMedGoogle Scholar
• Komatsu H, Takehana Y, Hamano S, et al. Beneficial effect of OKY-046, a selective thromboxane A2 synthetase inhibitor, on experimental cerebral vasospasm. Jpn J Pharmacol 1986;41:381-91
   PubMedGoogle Scholar
• Koumura A, Hamanaka J, Kawasaki K, et al. Fasudil and ozagrel in combination show neuroprotective effects on cerebral infarction after murine middle cerebral artery occlusion. J Pharmacol Exp Ther 2011;338:337-44
   PubMed Web of Science ®Google Scholar
• Istvan E. Statin inhibition of HMG-CoA reductase: a 3-dimensional view. Atheroscler Suppl 2003;4:3-8
   PubMed Web of Science ®Google Scholar
• Bonetti PO, Lerman LO, Napoli C, Lerman A. Statin effects beyond lipid lowering–are they clinically relevant? Eur Heart J 2003;24:225-48
   PubMed Web of Science ®Google Scholar
• Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 2001;81:153-208
   PubMed Web of Science ®Google Scholar
• Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998;97:1129-35
   PubMed Web of Science ®Google Scholar
• Dimitrova Y, Dunoyer-Geindre S, Reber G, et al. Effects of statins on adhesion molecule expression in endothelial cells. J Thromb Haemost 2003;1:2290-9
   PubMed Web of Science ®Google Scholar
• Lyngdoh T, Vollenweider P, Waeber G, Marques-Vidal P. Association of statins with inflammatory cytokines: a population-based Colaus study. Atherosclerosis 2011;219:253-8
   PubMed Web of Science ®Google Scholar
• Contermans J, Smit JW, Bar PR, Erkelens DW. A comparison of the effects of simvastatin and pravastatin monotherapy on muscle histology and permeability in hypercholesterolaemic patients. Br J Clin Pharmacol 1995;39:135-41
   PubMed Web of Science ®Google Scholar
• Thelen KM, Rentsch KM, Gutteck U, et al. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin. J Pharmacol Exp Ther 2006;316:1146-52
   PubMed Web of Science ®Google Scholar
• Tseng MY. Summary of evidence on immediate statins therapy following aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011;15:298-301
   PubMed Web of Science ®Google Scholar
• Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J 1984;108:188-93
   PubMed Web of Science ®Google Scholar
• Dubinsky JM, Brustovetsky N, Pinelis V, et al. The mitochondrial permeability transition: the brain's point of view. Biochem Soc Symp 1999;66:75-84
   PubMedGoogle Scholar
• Garcia LA, Dejong SC, Martin SM, et al. Magnesium reduces free radicals in an in vivo coronary occlusion-reperfusion model. J Am Coll Cardiol 1998;32:536-9
   PubMed Web of Science ®Google Scholar
• Ravn HB, Vissinger H, Kristensen SD, Husted SE. Magnesium inhibits platelet activity–an in vitro study. Thromb Haemost 1996;76:88-93
   PubMed Web of Science ®Google Scholar
• Shechter M. The role of magnesium as antithrombotic therapy. Wien Med Wochenschr 2000;150:343-7
   PubMedGoogle Scholar
• Golan E, Vasquez DN, Ferguson ND, et al. Prophylactic magnesium for improving neurologic outcome after aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis. J Crit Care 2013;28:173-81
   PubMed Web of Science ®Google Scholar
• Muroi C, Terzic A, Fortunati M, et al. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surg Neurol 2008;69:33-9
   PubMed Web of Science ®Google Scholar
• Dorhout Mees SM, Algra A, Vandertop WP, et al. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet 2012;380:44-9
   PubMed Web of Science ®Google Scholar
• Brewer RP, Parra A, Borel CO, et al. Intravenous magnesium sulfate does not increase ventricular CSF ionized magnesium concentration of patients with intracranial hypertension. Clin Neuropharmacol 2001;24:341-5
   PubMed Web of Science ®Google Scholar
• Mori K, Yamamoto T, Nakao Y, et al. Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 2009;49:139-44
   PubMed Web of Science ®Google Scholar
• Millar TM, Stevens CR, Benjamin N, et al. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett 1998;427:225-8
   PubMed Web of Science ®Google Scholar
• Pluta RM, Dejam A, Grimes G, et al. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. JAMA 2005;293:1477-84
   PubMed Web of Science ®Google Scholar
• Nagababu E, Ramasamy S, Abernethy DR, Rifkind JM. Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin-mediated nitrite reduction. J Biol Chem 2003;278:46349-56
   PubMed Web of Science ®Google Scholar
• Oldfield EH, Loomba JJ, Monteith SJ, et al. Safety and pharmacokinetics of sodium nitrite in patients with subarachnoid hemorrhage: a Phase IIA study. J Neurosurg 2013;119:634-41
   PubMed Web of Science ®Google Scholar
• Chen N, Yang M, Guo J, et al. Cerebrolysin for vascular dementia. Cochrane Database Syst Rev 2013;1:CD008900
   Google Scholar
• Windisch M, Gschanes A, Hutter-Paier B. Neurotrophic activities and therapeutic experience with a brain derived peptide preparation. J Neural Transm Suppl 1998;53:289-98
   PubMedGoogle Scholar
• Plosker G, Gauthier S. Cerebrolysin: a review of its use in dementia. Drugs Aging 2009;26:893-915
   PubMed Web of Science ®Google Scholar
• Akai F, Hiruma S, Sato T, et al. Neurotrophic factor-like effect of FPF1070 on septal cholinergic neurons after transections of fimbria-fornix in the rat brain. Histol Histopathol 1992;7:213-21
   PubMed Web of Science ®Google Scholar
• Hartbauer M, Hutter-Paie B, Windisch M. Effects of Cerebrolysin on the outgrowth and protection of processes of cultured brain neurons. J Neural Transm 2001;108:581-92
   PubMed Web of Science ®Google Scholar